SEROPREVALENCE OF RUBELLA AMONG THE WOMEN (WITH BAD OBSTETRIC HISTORY) VISITING A TERTIARY CARE HOSPITAL LOCATED IN CENTRAL INDIA

Main Article Content

Chandra Pratap Singh Rathore
Dr Amit Kumar
Dr Trupti Bajpai
Dr Dipak Patanvadia
Dr Pankti Pargi
Dr Rekha Kishori

Keywords

Rubella, Bad Obsteric History, Seroprevalence, IgG, IgM

Abstract

Background: Rubella is a mild exanthematous disease of global distribution. However, there is a risk of infection to the foetus subsequently causing congenital defects, if it infects susceptible pregnant women. Aims & Objective: To detect seroprevalence of Rubella in women with Bad Obstetric History.


Materials & Method: The present prospective study was carried out from June 2018 to May 2019 in the Department of Microbiology of a teaching tertiary care hospital located in the Central India. The serum samples received from 107 women with Bad Obstetric History were tested for TORCH panel. Rubella IgG & IgM antibodies were tested by ELISA method (Calbiotech, USA).


Results & Discussion: Among the 55 serum samples showing Rubella seropositivity, 10.9 % samples were IgM positive, 80 % were IgG positive and 9.09 % samples were found to be positive for both IgM & IgG antibodies. Several studies have also quoted the seroprevalence of Rubella ranging from 4.0 % to 29 %. Conclusions: The results indicate high prevalence of Rubella among the female with Bad Obstetric History. Serological screening has contributed to the prevention of congenital infection due to Rubella and also helps in proper management of fetal outcomes.


 

Abstract 184 | PDF Downloads 112

References

1. Sen MR, Shukla BN, Banerjee T.Prevalence of serum antibodies to TORCH infection in and around Varanasi, North India. J Clin Diag Res. 2012; 6, 1483-85.
2. Karad D, Kharat A. Seroprevalence of Torch Infections in Bad Obstetrics History in HIV and Non-HIV Women in Solapur District of Maharashtra India. J Human Vir and Retrovir. 2015; 2, 1-7.
3. Ramana BV, Reddy BK, Murty DS, Vasudevanaidu KH. Seroprevalance of Rubella in Women with Bad Obstetric History. Journal of Family Medicine and Primary Care January. 2013; 2, 44-6
4. Shetty M, Shivananda PG. Detection of IgM antibodies to Rubella in pregnant women by ELISA. Indian J Med Microbiol. 1993;11, 68-71.
5. Yashodhara P, Rama Lakshmi BA, Raman L, Naidu N. Rubella IgM positivity during pregnancy. Indian J Med Microbiol .1998; 16, 121-2.
6. Kumari N, Morris N, Dutta R. Is screening of TORCH worthwhile in women with bad obstetric history: an observation from eastern Nepal. 2011; J Health Pop Nutr. 29, 77-80.
7. Turbadkar D, Madhur M, Rele M. Seroprevalence of TORCH infection in bad obstetric history. 2003; Indian J Med Microbiol 21, 108-10.
8. Shrivastava G, Bhatambare GS, Patel KB. Seroprevalance of toxoplasma, rubella, CMV and HSV infection in pregnant women in central India. International J Health System and Disaster Management. 2014; 2, 166-9.
9. de Souza VA, Sumita LM, Otsubo ME, Takei K, Pannuti CS. Enzyme linked immunosorbent assay for Rubella antibodies: a simple method of antigen production. A preliminary report. Rev Inst Med Trop Sao Paulo. 1995; 37, 357-9.
10. Kaur R, Gupta N, Nair D, Kakkar M, Mathur MD. Screening for TORCH infections in pregnant women: A report from Delhi. Southeast Asian J Trop Med Public Health. 1999; 30, 284-6.
11. Thapliyal N, Shukla PK, Kumar B, Upadhyay S, Jain G. TORCH infection in women with bad obstetric history a pilot study in Kumaon region. Indian J Pathol Microbiol. 2005; 48, 551-3.
12. Barik S, Faruque F, Hossaini SS, Kar S, Mitra A, Sen S. Seroprevalence of Rubella in a Subfertility Clinic of a Semi Urban Tertiary Care Private Hospital of Eastern India. Int J Contemporary Med Res. 2020; 7, DOI: http://dx.doi.org/10.21276/ijcmr.2020.7.7.1.
13. Danovaro Holliday MC, LeBaron CW, Allensworth CW, Allensworth C, Raymond R, Borden TG, et al. A large rubella outbreak with spread from the workplace to the community. JAMA 2000; 284, 2733 9.
14. Ghazi HO, Telmesani AM, Mahomed MF. TORCH agents in pregnant Saudi women. Med Princ Pract. 2002; 11, 180 2.
15. El Mekki AA, Zaki ZM. Screening for rubella antibodies among Saudi women of child bearing age. Saudi Med J. 1998; 19, 575 7.
16. Pedranti MS, Adamo MP, Macedo R, Zapata MT. Prevalence of anti rubella and anti parvovirus B19 antibodies in pregnant women in the city of Córdoba, and in women of fertile age in the city of Villa Mercedes, province of San Luis. Rev Argent Microbiol 2007; 39, 47 50.
17. Kanbur N, Derman O, Kutluk T, Kinik E, Age specific rubella seroprevalance of an unvaccinated populatıon of adolescents in Ankara Turkey. Jpn J Infect Dis.2003; 56, 23 5.
18. Aksakal FN, Maral I, Cirak MY, Aygun R. Rubella seroprevalence among women of childbearing age residing in a rural region: Is there a need for rubella vaccination in Turkey. Jpn J Infect Dis. 2007; 60, 157 60.
19. Choi R, Oh Yejin, Oh Youngju, Kim SH, Lee SG, Lee EH. Recent trends in seroprevalence of rubella in Korean women of childbearing age: a cross-sectional study. BMJ Open. 2020; 10, 1-9.
20. Gilbert NL, Rotondo J, Shapiro J, Sherrard L, Fraser WD, Ward BJ. Seroprevalence of rubella antibodies and determinants of susceptibility to rubella in a cohort of pregnant women in Canada, 2008–2011. Vaccine. 2017; 23, 3050-55.

Most read articles by the same author(s)